EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers (original) (raw)

• Dobson, C.M. Protein folding and misfolding. Nature 426, 884–890 (2003).
  Article CAS Google Scholar
• Rochet, J.C. & Lansbury, P.T., Jr. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10, 60–68 (2000).
  Article CAS Google Scholar
• Taylor, J.P., Hardy, J. & Fischbeck, K.H. Toxic proteins in neurodegenerative disease. Science 296, 1991–1995 (2002).
  Article CAS Google Scholar
• Sacchettini, J.C. & Kelly, J.W. Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Discov. 1, 267–275 (2002).
  Article CAS Google Scholar
• Fowler, D.M., Koulov, A.V., Balch, W.E. & Kelly, J.W. Functional amyloid—from bacteria to humans. Trends Biochem. Sci. 32, 217–224 (2007).
  Article CAS Google Scholar
• Lansbury, P.T. & Lashuel, H.A. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443, 774–779 (2006).
  Article CAS Google Scholar
• Frieden, C. Actin and tubulin polymerization: the use of kinetic methods to determine mechanism. Annu. Rev. Biophys. Biophys. Chem. 14, 189–210 (1985).
  Article CAS Google Scholar
• Collins, S.R., Douglass, A., Vale, R.D. & Weissman, J.S. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol. 2, e321 (2004).
  Article Google Scholar
• Lomakin, A., Teplow, D.B., Kirschner, D.A. & Benedek, G.B. Kinetic theory of fibrillogenesis of amyloid β-protein. Proc. Natl. Acad. Sci. USA 94, 7942–7947 (1997).
  Article CAS Google Scholar
• Muchowski, P.J. & Wacker, J.L. Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6, 11–22 (2005).
  Article CAS Google Scholar
• Gosal, W.S. et al. Competing pathways determine fibril morphology in the self-assembly of β2-microglobulin into amyloid. J. Mol. Biol. 351, 850–864 (2005).
  Article CAS Google Scholar
• Cerda-Costa, N., Esteras-Chopo, A., Aviles, F.X., Serrano, L. & Villegas, V. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. J. Mol. Biol. 366, 1351–1363 (2007).
  Article CAS Google Scholar
• Rousseau, F., Schymkowitz, J. & Serrano, L. Protein aggregation and amyloidosis: confusion of the kinds? Curr. Opin. Struct. Biol. 16, 118–126 (2006).
  Article CAS Google Scholar
• Yang, D.S., Yip, C.M., Huang, T.H., Chakrabartty, A. & Fraser, P.E. Manipulating the amyloid-β aggregation pathway with chemical chaperones. J. Biol. Chem. 274, 32970–32974 (1999).
  Article CAS Google Scholar
• Serpell, L.C., Berriman, J., Jakes, R., Goedert, M. & Crowther, R.A. Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation. Proc. Natl. Acad. Sci. USA 97, 4897–4902 (2000).
  Article CAS Google Scholar
• Pellarin, R. & Caflisch, A. Interpreting the aggregation kinetics of amyloid peptides. J. Mol. Biol. 360, 882–892 (2006).
  Article CAS Google Scholar
• Cohen, F.E. & Kelly, J.W. Therapeutic approaches to protein-misfolding diseases. Nature 426, 905–909 (2003).
  Article CAS Google Scholar
• Shorter, J. & Lindquist, S. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol. Cell 23, 425–438 (2006).
  Article CAS Google Scholar
• Muchowski, P.J. et al. Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc. Natl. Acad. Sci. USA 97, 7841–7846 (2000).
  Article CAS Google Scholar
• Behrends, C. et al. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol. Cell 23, 887–897 (2006).
  Article CAS Google Scholar
• Tam, S., Geller, R., Spiess, C. & Frydman, J. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat. Cell Biol. 8, 1155–1162 (2006).
  Article CAS Google Scholar
• Kitamura, A. et al. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat. Cell Biol. 8, 1163–1170 (2006).
  Article CAS Google Scholar
• Conway, K.A., Rochet, J.C., Bieganski, R.M. & Lansbury, P.T., Jr. Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct. Science 294, 1346–1349 (2001).
  Article CAS Google Scholar
• Williams, A.D. et al. Structural properties of Aβ protofibrils stabilized by a small molecule. Proc. Natl. Acad. Sci. USA 102, 7115–7120 (2005).
  Article CAS Google Scholar
• Necula, M. et al. Methylene blue inhibits amyloid Aβ oligomerization by promoting fibrillization. Biochemistry 46, 8850–8860 (2007).
  Article CAS Google Scholar
• Ehrnhoefer, D.E. et al. Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum. Mol. Genet. 15, 2743–2751 (2006).
  Article CAS Google Scholar
• Masuda, M. et al. Small molecule inhibitors of α-synuclein filament assembly. Biochemistry 45, 6085–6094 (2006).
  Article CAS Google Scholar
• LeVine, H., III. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274–284 (1999).
  Article CAS Google Scholar
• Wood, S.J. et al. α-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J. Biol. Chem. 274, 19509–19512 (1999).
  Article CAS Google Scholar
• Bosco, D.A. et al. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization. Nat. Chem. Biol. 2, 249–253 (2006).
  Article CAS Google Scholar
• Weinreb, P.H., Zhen, W., Poon, A.W., Conway, K.A. & Lansbury, P.T., Jr. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709–13715 (1996).
  Article CAS Google Scholar
• Paz, M.A., Fluckiger, R., Boak, A., Kagan, H.M. & Gallop, P.M. Specific detection of quinoproteins by redox-cycling staining. J. Biol. Chem. 266, 689–692 (1991).
  CAS PubMed Google Scholar
• Craik, D.J. & Wilce, J.A. Studies of protein-ligand interactions by NMR. Methods Mol. Biol. 60, 195–232 (1997).
  CAS PubMed Google Scholar
• Bertoncini, C.W., Fernandez, C.O., Griesinger, C., Jovin, T.M. & Zweckstetter, M. Familial mutants of α-synuclein with increased neurotoxicity have a destabilized conformation. J. Biol. Chem. 280, 30649–30652 (2005).
  Article CAS Google Scholar
• Harper, J.D. & Lansbury, P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385–407 (1997).
  Article CAS Google Scholar
• Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486–489 (2003).
  Article CAS Google Scholar
• Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507–511 (2002).
  Article CAS Google Scholar
• El-Agnaf, O.M. et al. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett. 440, 71–75 (1998).
  Article CAS Google Scholar
• Goedert, M. & Spillantini, M.G. A century of Alzheimer's disease. Science 314, 777–781 (2006).
  Article CAS Google Scholar
• Bieschke, J., Zhang, Q., Powers, E.T., Lerner, R.A. & Kelly, J.W. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 44, 4977–4983 (2005).
  Article CAS Google Scholar
• Walsh, D.M. et al. Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945–25952 (1999).
  Article CAS Google Scholar
• Bennett, M.C. The role of α-synuclein in neurodegenerative diseases. Pharmacol. Ther. 105, 311–331 (2005).
  Article CAS Google Scholar
• Moore, D.J., West, A.B., Dawson, V.L. & Dawson, T.M. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57–87 (2005).
  Article CAS Google Scholar
• Iwai, A. et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467–475 (1995).
  Article CAS Google Scholar
• Fernandez, C.O. et al. NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J. 23, 2039–2046 (2004).
  Article CAS Google Scholar
• Porat, Y., Abramowitz, A. & Gazit, E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 67, 27–37 (2006).
  Article CAS Google Scholar
• Del Mar, C., Greenbaum, E.A., Mayne, L., Englander, S.W. & Woods, V.L., Jr. Structure and properties of α-synuclein and other amyloids determined at the amino acid level. Proc. Natl. Acad. Sci. USA 102, 15477–15482 (2005).
  Article CAS Google Scholar
• Bieschke, J., Siegel, S.J., Fu, Y. & Kelly, J.W. Alzheimer's Aβ peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)? Biochemistry 47, 50–59 (2008).
  Article CAS Google Scholar
• Tompa, P. Intrinsically unstructured proteins. Trends Biochem. Sci. 27, 527–533 (2002).
  Article CAS Google Scholar
• Mandel, S.A. et al. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 14, 46–60 (2005).
  Article CAS Google Scholar
• Khan, N., Afaq, F., Saleem, M., Ahmad, N. & Mukhtar, H. Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate. Cancer Res. 66, 2500–2505 (2006).
  Article CAS Google Scholar
• Kocisko, D.A. et al. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol. 77, 10288–10294 (2003).
  Article CAS Google Scholar
• Zhu, N. et al. Identification of oxidation products of (−)-epigallocatechin gallate and (−)-epigallocatechin with H2O2 . J. Agric. Food Chem. 48, 979–981 (2000).
  Article CAS Google Scholar
• Dedmon, M.M., Lindorff-Larsen, K., Christodoulou, J., Vendruscolo, M. & Dobson, C.M. Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J. Am. Chem. Soc. 127, 476–477 (2005).
  Article CAS Google Scholar
• Eliezer, D., Kutluay, E., Bussell, R. Jr. & Browne, G. Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061–1073 (2001).
  Article CAS Google Scholar